High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukemia and known clinical outcome in southern Brazil

Leukemia Research

Volumn 28, Issue 10, 2004, Pages 1033-1038

  Veiga, Loraine Beatriz Acosta ^a   Cóser, Virginia Maria ^b   Cavalli, Luciane Regina ^c   Cavalli, Iglenir João ^a   Rodrigues, Jacqueline Nunes ^b   Pereira, Waldir Veiga ^b   Pereira, Dalnei Veiga ^b   Lafayette, Thereza Christina Sampaio ^b   Villalba, Benônio Terra ^b   Moreira, Mauber Eduardo Schultz ^b   Haddad, Bassem R ^c   Ribeiro, Enilze Maria De Souza Fonseca ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

AML1 TEL fusion; Clinical outcome; Cytogenetics; FISH; Pediatric ALL; t(12:21)

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; BRAZIL; CHILD; CHROMOSOME 12; CHROMOSOME 21; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CLONAL VARIATION; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE LOCUS; GENETIC IDENTIFICATION; HUMAN; INFANT; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BRAZIL; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 3843070996     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.02.004     Document Type: Article

References (29)

1. Raimondi S.C., Williams D.L., Callihan T., Peiper S., Rivera G.K., Murphy S.B. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood. 68:1986;69-75
2. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 81:1993;2237-2251
3. Raimondi SC, Mathew S, Pui CH. Cytogenetics as a diagnostic aid for childhood hematologic disorders. In: Hanausek Mwalaszek Z, editors. Methods in molecular medicine, tumors markers protocols. vol. 14. Totowa, NJ: Humana Press; 1998. p. 209-27.
4. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316
5. Romana S.P., Le Coniat M., Berger R. t(12:21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chrom Cancer. 9:1994;186-191
6. Wiemels J.L., Greaves M. Structure and possible mechanisms of TEL/AML1 gene fusion in childhood acute lymphoblastic leukemia. Cancer Res. 59:1999;4075-4082
7. Shurtleff A.S., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., et al. TEL/AML1 fusion resulting from a cryptic t(12:21) is the most common genetic lesion in pediatric ALL and a subgroup of patients with an excellent prognosis. Leukemia. 9:1995;1985-1989
8. Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C., Bray-Ward P., et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 92:1995;4917-4921
9. Liang D.C., Chou T.B., Chen J.S., Shurtleff S.A., Rubnitz J.E., Downing J.R., et al. High incidence of TEL/AML1 fusion resulting from a cryptic t(12:21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia. 10:1996;991-993
10. Harbott J., Viehmann S., Borkhardt A., Henze G., Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood. 90:1997;4933-4937
11. Rubnitz J.E., Downing J.R., Pui C.H., Shurtleff A.S., Raimondi S.C., Evans W.E., et al. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol. 15:1997;1150-1157
12. Brandalise SR, Odone-Filho V, Pereira WV, D'Andrea MLM, Zanichelli MA Anarenga V. Treatment results of three consultive brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85, Leukemia 1993;7:(Suppl 2):142-45.
13. Ribeiro E.M., Cavalli I.J., Schmid A.T., Cornelio D.A., Tokutake A.S., Sperandio-Roxo V.M., et al. Cytogenetic analysis in human bone marrow transplantation. Cancer Genet Cytogenet. 89(1):1996;21-26
14. Mitelman F, editor. ISCN, an international system for human genetic nomenclature. Basel: S. Karger; 1995.
15. Hardwick M., Cavalli L.R., Barlow K.D., Haddad B.R., Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) gene amplification in MDA-MB-231 aggressive breast cancer cells. Cancer Genet Cytogenet. 139:2002;48-51
16. Beiguelman B. Curso Prático de Bioestatística. Ribeirão Preto, SP: Brazilian Journal of Genetics; 1988.
17. Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M.G., Ludwig W.D., Burci L., et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood. 90:1997;571-577
18. Cavé H., Caheux V., Raynaud S., Brunie G., Bakkus M., Cochaux P., et al. ETV6 is the target of chromosome 12p deletions in t(12:21) childhood acute lymphoblastic leukemia. Leukemia. 11:1997;1459-1464
19. Spathas D.H., Stewwart J., Singer I.O., Theriault A., Bovey M., Connor J.M. Detection of t(12:21) in childhood acute lymphoblastic leukemia by fluorescence in situ hybridization. Cancer Genet Cytogenet. 110:1999;7-13
20. Inamdar N., Kumar A.S., Banavali S.D., Advani S., Magrath I., Bhatia K. Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pedriatric precursor B acute lymphoblastic leukemias in India. Int J Oncol. 13:1998;1319-1322
21. Park K.U., She C.J., Shin H.Y., Ahn H.S., Kim C.J., Cho B.K., et al. Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization. Cancer Genet Cytogenet. 126:2001;73-77
22. Garcia-Sanz R., Alaejos I., Orfao A., Rasilio A., Chillon M.C., Tabernero M.D., et al. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain. Br J Haematol. 107:1999;667-669
23. Sawinska M, Ladon D. Mechanism, detection and clinical significance of the reciprocal translocation t(12,21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia. Leuk Res 2004;28:35-42.
24. Zen PRG, Lima MC, Cóser VM, Silla L, Daudt L, Fernandes MS, et al. Prevalence of TEL/AML1 (ETV6/CBFA2) fusion identified by fluorescence in situ hybridization in Brazilian pediatric patients with acute lymphoblastic leukemia. Cancer Genet Cytogenet 2003, in press.
25. Yehuda-Gafni O., Cividalli G., Abrahmov A., Weintrob M., Neriah S.B., Cohen R., et al. Fluorescence in situ hybridization analysis of the cryptic t(12:21)(p13;q22) in childhood B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet. 132:2002;61-64
26. Douet-Guilbert N., Morel F., Le Bris M.J., Herry A., Calvez G.L., Marion V., et al. A fluorescence in situ hybridization study of TEL-AML1 fusion gene in B-cell acute lymphoblastic leukemia (1984-2001). Cancer Genet Cytogenet. 144:2003;143-147
27. Martinez-Ramirez A., Urioste M., Contra T., Cantalejo A., Tavares A., Portejo J.A., et al. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes: correlation with cytogenetic findings and prognostic value in children with acute lymphoblastic leukemia. Haematologica. 86:2001;1245-1253
28. Busson-Le Coniat M., Nguyen K.F., Daniel M.T., Bernard A.O., Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chrom Cancer. 32:2001;244-249
29. Jamil A., Theil K.S., Kahwash S., Ruymann F.B., Klopfenstein K.J. TEL/AML-1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet.Cytogenet. 122:2000;73-78